High inbreeding in the Faroe Islands does not appear to constitute a risk factor for multiple sclerosis

Abstract

Background:

Large population-based genome-wide association studies have identified several multiple sclerosis (MS) genetic risk variants, but the existing missing heritability warrants different strategies. Isolated populations offer an alternative way of searching for rare genetic variants and evaluating the possible role of consanguinity in the development of MS. Studies of consanguinity and MS risk have yielded conflicting results.

Objectives:

In this study we investigated the role of consanguinity on MS risk in the relatively isolated Faroe Islands, which have a presumed high level of inbreeding.

Methods:

A total of 29 cases and 28 matched controls were genotyped and assessed for inbreeding coefficients, number of runs of homozygosity (ROH) at different lengths and observed number of homozygotes as measures of relatedness. Parametric and non-parametric statistical models were applied.

Results:

Both cases and controls exhibited considerable relatedness demonstrated by very high inbreeding coefficients, large number of observed homozygotes and many long ROH. However, apart from the number of ROH ≥ 2.5 mega base pairs, no significant differences between the two groups were observed.

Conclusions:

Overall, no significant difference between cases and controls were found, indicating that consanguinity in itself does not appear to be an important risk factor for MS in the population of the Faroe Islands.

Keywords

Multiple sclerosis genetics inbreeding Faroe Islands runs of homozygosity risk factors

Get full access to this article

View all access options for this article.

References

Compston

Coles

. Multiple sclerosis. Lancet 2008; 372: 1502–1517.

Patsopoulos

; Bayer Pharma MS Genetics Working Group; Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011; 70: 897–912.

International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham

Patsopoulos

. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353–1360.

Watson

Disanto

Breden

. Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs. Sci Rep 2012; 2: 770.

Jakkula

Leppä

Sulonen

. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 2010; 86: 285–291.

Dessa Sadovnick

Yee

Ebers

. Recurrence risks to sibs of MS index cases: Impact of consanguineous matings. Neurology 2001; 56: 784–785.

Al Jumah

Kojan

Al Khathaami

. Familial multiple sclerosis: Does consanguinity have a role? Mult Scler 2011; 17: 487–489.

Roberts

. Consanguinity and multiple sclerosis in Orkney. Genet Epidemiol 1991; 8: 147–151.

Hoppenbrouwers

Cortes

Aulchenko

. Familial clustering of multiple sclerosis in a Dutch genetic isolate. Mult Scler 2007; 13: 17–24.

10.

Binzer

Forsgren

Holmgren

. Familial clustering of multiple sclerosis in a northern Swedish rural district. J Neurol Neurosurg Psychiatry 1994; 57: 497–499.

11.

Callander

Landtblom

. A cluster of multiple sclerosis cases in Lysvik in the Swedish county of Värmland. Acta Neurol Scand 2004; 110: 14–22.

12.

Cocco

Sardu

Massa

. Epidemiology of multiple sclerosis in south-western Sardinia. Mult Scler 2011; 17: 1282–1289.

13.

Roberts

Poskanzer

. Genetic analysis of multiple sclerosis in Shetland. J Epidemiol Community Health 1983; 37: 281–285.

14.

Jorgensen

Buttenschön

Wang

. The origin of the isolated population of the Faroe Islands investigated using Y chromosomal markers. Hum Genet 2004; 115: 19–28.

15.

Als

Jorgensen

Børglum

. Highly discrepant proportions of female and male Scandinavian and British Isles ancestry within the isolated population of the Faroe Islands. Eur J Hum Genet 2006; 14: 497–504.

16.

Kurtzke

Hyllested

. Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features. Ann Neurol 1979; 5: 6–21.

17.

Binzer

Imrell

Binzer

. Multiple sclerosis in a family on the Faroe Islands. Acta Neurol Scand 2010; 121: 16–19.

18.

Purcell

Neale

Todd-Brown

. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.

19.

McWhirter

McQuillan

Visser

. Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders. Eur J Hum Genet 2012; 20: 198–202.

20.

McQuillan

Leutenegger

Abdel-Rahman

. Runs of homozygosity in European populations. Am J Hum Genet 2008; 83: 359–372.

21.

Joensen

. Incidence of amyotrophic lateral sclerosis in the Faroe Islands. Acta Neurol Scand 2012; 126: 62–66.

22.

Lund

Joensen

Hougaard

. Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe Islands. J Inherit Metab Dis 2007; 30: 341–349.

23.

Poulsen

Lund

Christensen

. Carnitine transporter deficiency is a hereditary disease with a high incidence in the Faroe Islands [article in Danish]. Ugeskr Laeger 2012; 174: 1217–1219.